Current Medicine Around the World
2022 - July
The Effect of Heparin Lock and Topical Antibiotics on Catheter-Related Bloodstream Infection Events in Chronic Kidney Disease with Short-Term Double-Lumen Catheter Patients
Hery Siswanto, Muhammad Nuralim Mallapasi, Mulawardi, Jayarasti Kusumanegara, Umar Usman, Burhanuddin Bahar, Haerani Rasyid, Muhammad Faruk
Current Medicine Around the World, 2022 - July
Article DOI: 10.21614/sgo-eC-429
Introduction: Catheter-related bloodstream infection (CRBSI) is a complication that can occur in hemodialysis patients, especially when a double-lumen catheter (DLC) is used. This study aimed to investigate the effect of heparin lock and topical antibiotics on the incidence of CRBSI in chronic kidney disease (CKD) patients using DLC.

Methods: This randomized, preâ?"post-control design study was conducted on adult patients undergoing routine hemodialysis. Patients were divided equally into two groups. In addition to the standard protocol, the first group was given a combination therapy of heparin lock (20 mg mL heparin left in DLC for 4 hours) and mupirocin 5% cream at the DLC exit area, and the second group was only given a single heparin lock. The diagnosis of CRBSI was made based on the Infectious Diseases Society of America criteria. Numerical data were analyzed using the t-test and Mann Whitney U test. Categorical data were analyzed using the chi-square test. A p-value of <0.05 was considered significant.

Results: Of the 40 patients (20 male and 20 female) in this study, 62.5% were between the ages of 41â?"60 years. CRBSI was found in 10 patients (25%), with a higher incidence in the single-therapy group (8 cases; p < 0.05). The single-therapy group also tended to have CRBSI faster, with a hazard ratio of 7.61.

Conclusion: The application of the topical antibiotic mupirocin might be effective in reducing the risk of CRBSI in CKD patients using DLC.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 1685


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Jun 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.